Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2025-12-17 @ 4:58 AM
Study NCT ID:
NCT04760730
Status:
None
Last Update Posted:
2022-10-26 00:00:00
First Post:
2021-02-17 00:00:00
Brief Title:
Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
Sponsor:
R-Pharm
Organization:
R-Pharm
Organization Data
Organization:
R-Pharm
Class:
INDUSTRY
Study ID:
CV03872091
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
R-Pharm
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |